Discovery of BGM1812, a Novel Dual Amylin and Calcitonin Receptor Agonist for Obesity Treatment Journal of Medicinal Chemistry Cagrilintide: The Peptide That Makes You Forget About Food. I call it the silence between cravings. Cagrilintide is a long acting amylin analog which means it works alongside leptin and GLP 1 to The Obesity Wars of 2026 continue: Novo's Miss, Lilly's Supremacy, and the Quality of Weight Loss Pivot Targeting the incretin system in obesity and type 2 diabetes mellitus Nature Reviews Endocrinology Let me introduce you to a NEW peptide : Cagrilintide is an amylin analog which is now being developed in combination with GLP 1 agonist Semaglutide to achieve sustained